Review of the available literature obtained from both acute and chronic experiments utilizing rats, mice and chickens treated with C1O2, C102-and C103-in drinking water has demonstrated alterations in hematologic parameters in all species tested. The effects were usually dose related and marked changes occurred only at the higher dosages (up to 1000 mg/I.). In chronic studies, rats have been given C102 at doses of up to 1000 mg/l., and NaClO2 or NaClO3 at up to 100 mg/l., in their drinking water for one year. Treatment groups receiving C102, C102-or C103-showed alterations in erythrocyte morphology and osmotic fragility; at higher dosages mild hemolytic anemia occurred. An examination of blood glutathione content and RBC enzymes involving glutathione formation showed a dose-related diminution of glutathione in chlorine compound treated groups. The higher oxidative capacity of the chlorine compounds resulting in the decreased erythrocytic glutathione might well be the principal biochemical event leading to the other hematological alterations.
Introduction
Institution of disinfection to drinking water treatment has been one of the key successes of public health policy. In the United States almost complete dependence has been placed on chlorine for primary disinfection. In recent years, however, it has become clear that treatment of drinking water with chlorine results in the formation of trihalomethanes (1, 2) . One of the trihalomethanes, chloroform, has been shown to be carcinogenic in mice and rats (3) .
These observations stimulated a search for a means to minimize the formation of these products. One of the most attractive alternatives is to substitute disinfection methods that do not promote the formation of chlorinated by-products.
Chlorine dioxide is a very attractive alternative to chlorine as a disinfectant. For all intents and purposes its disinfectant properties are equivalent to or perhaps exceed those of chlorine (4) . Chlorine dioxide does not react with phenol to produce the same taste and odor problems that result from chlorine treatment (5) . It has the added advantage that formation of trihalomethanes does not occur (6, 7) .
Prior to the recent consideration of chlorine dioxide as a primary disinfectant for potable water, very little information existed concerning its toxi-cology. The use of chlorine dioxide for this purpose also requires consideration of by-products of its use that will occur in the consumed product, chlorite (C102-) and chlorate (Cl03. Chlorite occurs both as a result of being the first reduction product in oxidative reactions in which C102 participates and because C102 is often generated by acidifying a sodium chlorite feed solution. Chlorate on the other hand arises primarily by a disproportionation reaction of C102 that is catalyzed by ultraviolet light (8) , giving rise to one molecule of C102-and one molecule of C103-per two molecules of C102.
As a result of the interest in C102 as a primary disinfectant, a number of studies have been initiated to investigate the toxicity associated with C102, C102-and C103-. This paper reviews the literature which has resulted from these investigations and attempts to deal with the mechanisms involved with the cellular damage induced by these agents.
Hematologic Effects
Rats, mice and chickens have been treated with C102, C102 and/or C103-in drinking water at concentrations ranging from 1 to as high as 1000 mg/l. A relatively consistent picture has been observed across species. In the rat, Heffernan et al. (9) demonstrated that chlorite concentrations of 100 mg/l. and above resulted in decreased red blood cell counts, hemoglobin concentrations and packed cell volume at 30 and 60 days of exposure. These effects tended to be reversed by 90 (10) as well as the rat and chicken (12) . These COURI, ABDEL-RAHMAN AND BULL changes were quite marked at concentrations of 100 mg Cl0-/l. ranging from mildly crenated erythrocytes which maintained their discoid shape to crenated spheres (echinocytes). With C103-treatment, codocytes (Mexican hat-shaped) were also observed in the rat. In the chicken, the characteristic abnormality was the dacrocyte, which was evident primarily with C102 treatments of 100 and 1000 mg/I. Early studies had somewhat paradoxically indicated that C102, C102 and C103-decreased osmotic fragility of erythrocytes isolated from treated animals (12) . Subsequent experiments have shown this effect is most likely due to the oxidation of thiol groups resulting in the precipitation of hemoglobin to give falsely low indications of hemolysis (13) . This is also consistent with the in vitro observations of Heffernan et al. (14) that a complete loss of measurable pigment (both hemoglobin and methemoglobin) occurred at high concentrations of C102-.
Biochemical Effects
Early reports had documented the ability of C102-to oxidize hemoglobin to methemoglobin by high intraperitoneal doses (320 mg/kg) (15).
Heffernan et al. (9) confirmed these observations using intraperitoneal doses in the rat and bolus oral doses of C102-in the cat. However, in studies where C102, Cl02-or C103-was included in the drinking water for up to several months, no significant increases in methemoglobin concentrations resulted with doses as high as 1000 mg/I. in the rat, mouse or chicken (9, 10, 12) .
Therefore, although a real hazard with large bolus doses, methemoglobinemia appears to be an unlikely hazard at concentrations of C102, C102 and C103-which might be anticipated to be associated with drinking water treatment. Heffernan et al. (9) reported that C102-incubated with RBC in vitro depleted these cells of glutathione and increased the level of hydrogen peroxide produced as measured by catalase complex 1 formation. These in vitro studies clearly demonstrated that virtually complete loss of glutathione occurred before there was significant accumulation of methemoglobin. Additionally, these studies demonstrated a biphasic consumption of added C102-, one phase of which was associated with hydrogen peroxide generation and glutathione depletion and the other with hemoglobin oxidation. The changes in erythrocyte morphology by scanning electron microscopy in vitro paralleled exactly the progression observed with C102 treatment in subsequent in vivo experiments (10, 12) .
From these data it was clear that C102-possesses the types of activity associated with chemicals that produce oxidative hemolysis in vivo (16) (17) (18) (11, 13) .
The recovery or nonrecovery of glutathione levels with continued treatment in vivo appeared at least partially dependent upon a complex set of interactions with redox systems operating in the rat erythrocyte (19) . The reversibility of the C102 effect appears to result from increased levels of glutathione reductase activity in the red cell following 6 months oftreatment. In the case of C103-there appears to be no such adaptive increase in this enzyme level. With C102-the glutathione reductase levels do increase to levels comparable to those observed with C102. However, this adaptive change appears to be offset by significantly depressed levels of catalase in the red cell with Cl02-treatment.
The importance of the changes in enzyme levels in the adaptation to chronic C102 exposure has been indirectly supported by the data of Heffernan et al. (9, 14) . First, the addition of glucose to red cells treated with CI02-in vitro partially protects against depletion of glutathione. Glutathione peroxidase is the principal means of disposing of hydrogen peroxide in the red cell (17) . Glucose serves as the carbon source which donates the reducing equivalents necessary for the reduction of oxidized glutathione (17, 20) .
Secondly, in vivo treatment with Cl02-greatly enhances the formation of C102--induced formation of hydrogen peroxide in vitro. Clearly in vivo treatment with C102-reduces the ability of the red cell to dispose of hydrogen peroxide. Although the animal is not seriously ill at levels of C102, C102-or C103-considerably exceeding those contemplated in drnking water treatment, the body's ability to adapt to oxidant stress is compromised at relatively low concentrations of these chemicals. 15 These considerations focus attention on populations known to be sensitive to oxidants, for example, those deficient in glucose-6-phosphate dehydrogenase. Such individuals are known to be considerably more sensitive to oxidant stress than normal humans. As will be discussed in other papers in this symposium, erythrocytes isolated from such individuals are three to four times as susceptible to C102--induced damage than normal human red cells (21) . In this regard, Michael et al. (22) conducted a human study in a small town which utilized C102 in combination with chlorine as a primary disinfectant during the summer months. Concentrations of C102, C102-and C103 were not closely controlled but the total of their concentrations averaged 5-7 mg/l. In this situation normal humans were not apparently affected. However, the only individual in the community deficient in glucose-6-phosphate dehydrogenase experienced a substantial decrease in hemoglobin levels and hematocrit. With only one case it is difficult to conclusively ascribe this change to C102 or its by-products, but it does suggest reason for concern about sensitive populations.
Evidence of Damage to Other Tissues
Research examining nonhematologic effects of C102, C102-and C103-is sparse. Distribution and clearance of 36CI derived from C102, Cl02-or Cl03-is widespread throughout all organs including bone marrow (12, 23, 24) .
There is some evidence of macromolecular binding in the liver. These findings raised the question of whether or not cellular types in addition to the red cell are similarly targeted by these chemicals.
The gastrointestinal mucosa is the obvious first potential target of residual disinfectant species. Abdel-Rahman et al. (11) examined the incorporation of 3H-thymidine into nuclei of cells of the intestinal mucosa of the rat as a measure of the turnover of these cells. At levels of 10 mg/l. of C102 and C102-in drinking water for 3 months, there were significant increases in 3H-thymidine incorporation, implying an increased turnover of intestinal epithelium. No effect was observed with equivalent concentrations of C103-. Unfortunately, lower levels of exposure to C102 and C102-were not examined.
Examination of other organs revealed that C102 treatment inhibited 3H-thymidine incorporation into nuclei of cells in the kidney and testes of the rat.
C102-produced similar effects in the testes and markedly inhibited 3H-thymidine incorporation in the liverat 10 and 100mg/I. Cl03-produced significant effects only in the testes. At 100 mg/l, C102-also inhibited the incorporation of 'H-thymidine into the gastrointestinal mucosa and C102 produced a smaller increase than had been observed with 10 mg/l. These data suggest that at high doses in the intestinal mucosa and at lower doses in testes and liver, C102 and/or its by-products is interfering with DNA synthesis. The significance of these results is presently difficult to determine. But since a large portion of the DNA synthesis ongoing in testes is associated with spermatogenesis, these results cannot be lightly dismissed. Consequently, it is essential that this work be followed up with studies of the reproductive toxicity of these chemicals and be extended to lower doses.
Conclusions
It is clear from this brief review that substantial questions remain to be answered concerning the safety of C102 as a primary disinfectant of drinking water. Although C102, C102-and C103-have been used extensively in drinking water treatment, actual human exposure has been limited in the past because the concentrations proposed for taste and odor control are much lower than required for primary disinfection. Europeans have used C102 as a primary disinfectant, but again levels which have been used are quite low because disinfectants are employed after much of the organic material has been removed from the water by granular activated carbon, a practice not common in the U.S. Consequently, only in certain very limited circumstances have epidemiological evaluations been possible and appropriate to the use of C102 as a primary disinfectant. Consequently, it appears that further experimental work will be necessary to more clearly identify and quantify the hazards involved with its use.
Three major areas of concern over the use of CO02 as a disinfectant have been identified by research performed to date. First, there is a need to study human populations which display higher levels of sensitivity to oxidant chemicals. Second, efforts must be made to determine the significance of increased turnover of the epithelium of the gastrointestinal tracts at low doses of C102 and C102 . This tissue normally turns over quite rapidly. On the other hand, cellular damage followed by regeneration has been associated with increased susceptibility to chemical carcinogens in other organs such as the liver (25) . Third, and perhaps most important, is the question of potential reproductive effects of C102 and its by-products implied, but not established, by the reduced incorporation of 3H-thymidine into testicular DNA. The fact that this effect occurred at quite low doses of C102, C102-and C103-raises the level of concern considerably. It should be noted that similar effects were not observed with HOCI (11) .
In summary, there is little conclusive evidence to prevent the use of C102 as a disinfectant at present. On the other hand, there are scattered pieces of indirect evidence that would advise caution about instituting the use of C102 as a primary disinfectant in place of chlorine. This is complicated by the fact that the total concentration of CG02, C102 and C1O3-might reach several parts per million in the absence of removing background organic material to be an effective disinfectant. It is obvious that this question can only be finally resolved through further research.
